Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LETERMOVIR Cause Cytomegalovirus infection? 87 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 87 reports of Cytomegalovirus infection have been filed in association with LETERMOVIR (PREVYMIS). This represents 6.1% of all adverse event reports for LETERMOVIR.

87
Reports of Cytomegalovirus infection with LETERMOVIR
6.1%
of all LETERMOVIR reports
5
Deaths
11
Hospitalizations

How Dangerous Is Cytomegalovirus infection From LETERMOVIR?

Of the 87 reports, 5 (5.7%) resulted in death, 11 (12.6%) required hospitalization, and 1 (1.1%) were considered life-threatening.

Is Cytomegalovirus infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LETERMOVIR. However, 87 reports have been filed with the FAERS database.

What Other Side Effects Does LETERMOVIR Cause?

Off label use (277) Drug ineffective (103) Product use in unapproved indication (99) Death (98) Cytomegalovirus infection reactivation (89) No adverse event (69) Hospitalisation (60) Drug interaction (57) Pathogen resistance (57) Product dose omission issue (54)

What Other Drugs Cause Cytomegalovirus infection?

TACROLIMUS (3,320) MYCOPHENOLATE MOFETIL (3,278) CYCLOSPORINE (1,897) PREDNISOLONE (1,732) PREDNISONE (1,719) CYCLOPHOSPHAMIDE (1,584) METHYLPREDNISOLONE (1,578) RITUXIMAB (1,494) FLUDARABINE (1,132) VALGANCICLOVIR (1,091)

Which LETERMOVIR Alternatives Have Lower Cytomegalovirus infection Risk?

LETERMOVIR vs LETROZOLE LETERMOVIR vs LETROZOLE\RIBOCICLIB LETERMOVIR vs LEUCOVORIN LETERMOVIR vs LEUCOVORIN\LEUCOVORIN LETERMOVIR vs LEUPROLIDE

Related Pages

LETERMOVIR Full Profile All Cytomegalovirus infection Reports All Drugs Causing Cytomegalovirus infection LETERMOVIR Demographics